German pharmaceutical wholesaler Fiebig goes live with IBS Pharma

German pharmaceutical wholesaler Fiebig goes live with IBS Pharma 

Pharmaceutical wholesaler Leopold Fiebig has now fully implemented the IBS
Pharma for its industry-specific, highly customized financial accounting
processes which, as a result, are now completely integrated with the entire
business 

STOCKHOLM, November 16, 2009 - International Business Systems (STO: IBS B) the
leading application supplier for wholesale and distribution, today announced the
first German customer going live with the IBS Pharma product. The customer,
Leopold Fiebig GmbH & Co. KG, a renowned pharmaceutical wholesaler based in
Rheinstetten, has replaced its proprietary legacy finance solution with a
future-proof standard software which meets all the specific requirements of the
industry and is seamlessly integrated with the existing IT application
eco-system. This includes handling of pricing models, invoicing patterns and
terms and conditions that vary greatly between customers. Fiebig has opted for
the hosting services model offered by IBS as an alternative to the traditional
licensing model and data are stored at the IBS data processing centre which
Fiebig accesses remotely.

"After a series of successful tests we gave the green light and have been live
with IBS Pharma since 1st October 2009", says Klaus Görke, Managing Director at
Fiebig. "As early as this November our pharmacies received summary invoices
which had been created with IBS Pharma for the first time. As was to be
expected, everything went smoothly. We are very happy that we have reached our
goal of establishing a flexible pricing model on the standardized basis of a
stable and seamlessly integrated system. And, seen from a management point of
view our financial accounting processes have become much more efficient."

"We are very happy about this joint project we concluded so successfully. This
was only possible through exemplary co-operation between client company and
solution vendor," declares Bas Broekarts, IBS Vice President Sales Europe. "We
have reached an important milestone on our way to establishing IBS Pharma also
in Germany."
 
For more information, please contact:
Oskar Ahlberg, Senior Vice President of Communications, IBS AB
Tel: +46-70-244 24 75
oskar.ahlberg@ibs.net


German press contact:
ars publicandi GmbH
Martina Overmann
Schulstraße 28
D-66976 Rodalben
Tel.: +49/6331/5543-13, Fax: -43

MOvermann@ars-pr.de
www.ars-pr.de
Author: Andreas Becker 

About IBS
IBS specialises in differentiating companies from their competitors on the
strength of their distribution operations. 
Founded in 1978, IBS has over 30 year's experience of distribution in industries
ranging from automotive and electronics to paper, publishing and
pharmaceuticals. This deep understanding of distribution models and best
practices is embodied in IBS' global distribution system, which is enhanced with
local expertise to create a unique system for each IBS client. 

More than 4,000 companies in 40 countries rely on IBS to improve their
distribution operations - enabling them to achieve both increased profitability
and higher valued services to the channel.

IBS B share is listed on NASDAQ OMX First North Exchange Stockholm. For more
information, please visit www.ibs.net

About Leopold Fiebig 
Leopold Fiebig GmbH & Co. KG, headquartered in Rheinstetten, is an independent,
privately run full-line distributor with a history of more than 100 years. The
85 employees of the medium-sized pharmaceutical wholesaler provide pharmacies in
Southwestern Germany with prescription medicine, OTC drugs and various lifestyle
products. The company covers an area stretching from Idar-Oberstein to Müllheim,
from Primasens to Schwäbisch Hall. In their state-of-the-art logistics centre,
where some 80,000 items are continuously in stock, Fiebig reaches an automation
degree of 90% in the logistics area. As a result, up to 2,400 orders can be
processed per hour, with a maximum throughput time of just 15 minutes from
receipt of order to loading of goods. Please refer to http://www.fiebig.de for
more information.